论文部分内容阅读
AIM: To investigate effects of cyclooxygenase 2 (COX-2) inhibitors on nasopharyngeal carcinoma (NPC) cells and on angiogenesis in vitro. METHODS: Human NPC cell lines (CNE1, CNE2 and SUNE) were treated with nimesulide or celecoxib. MTT assay and colony formation assay were performed to observe antiproliferation activity of COX-2 inhibitors to NPC cell lines. Cell cycle arrest and apoptosis of NPC cell strains were tested by flow cytometry assay, microscopic morphology observation, and DNA fragmentation assay. The effect of COX- 2 inhibitor on angiogenesis was tested by chick chorioallantoic membrane (CAM) model. RESULTS: Nimesulide (Nim) and celecoxib (Cel) could antiproliferate NPC cell lines with IC50 182 μmol/LNim-SUNE, 78 μmol/LNim-CNE1, 175 μmol/LNim-CNE2, 7.2 μmol/LCel-SUNE, 8.1 μmol/LCel-CNE1, and 7.6 μmol/LCel-CNE2. The antiproliferation presented dose- dependent (Nim5-400 μmol/L, Cel 0.5-80μmol/L) and time-dependent manner (Nim IC50 562 μmol/L24 , 316 μmol/L48 , h h 50.1 μmol/L240 ). Nim and Cel arrested SUNE and CNE1 cell cycle at phase G2/M (cell aggregation rate 28.9 %- h 45.1 %Nim 25-200μmol-12 h-SUNE , 18.9%-26.2 %Nim 25-200μmol-24 h-SUNE ,28.8 %-35.6%Nim 25-200 μmol-48 h-SUNE ,30.4 %-16.4%Cel 25-100μmol-12 h-SUNE , 21.2 %-19.7 %Cel 25-100 μmol-24 h-SUNE, 31.1 %-19.9 %Cel 25-100 μmol-24 h-SUNE, 20.5 %-34.1 %Nim25-200 μmol-12 h-CNE1, 25.2 %- 26.9 %Nim 25-200 μmol-24 h-CNE1 , 11.5 %-7.1 %Nim 25-200 μmol-48 h-CNE1). Apoptosis shape and apoptosis strap displayed in NPC cells after treatment with Nim and Cel. Nim had a feature of anti-angiogenesis on CAM model. CONCLUSION: Nim and Cel could suppress proliferation of squamous epithelium NPC cell (SUNE, CNE1 and CNE2) through blocking cell cycle and inducing cell apoptosis. Nim could apparently suppress CAM angiogenesis induced by
AIM: To investigate effects of cyclooxygenase 2 (COX-2) inhibitors on nasopharyngeal carcinoma (NPC) cells and on angiogenesis in vitro. METHODS: Human NPC cell lines (CNE1, CNE2 and SUNE) were treated with nimesulide or celecoxib. MTT assay and colony formation assay were performed to observe antiproliferation activity of COX-2 inhibitors to NPC cell lines. Cell cycle arrest and apoptosis of NPC cell strains were tested by flow cytometry assay, microscopic morphology observation, and DNA fragmentation assay. The effect of COX- 2 Inhibitors on angiogenesis were tested by chorioallantoic membrane (CAM) model. RESULTS: Nimesulide (Nim) and celecoxib (Cel) could antiproliferate NPC cell lines with IC50 182 μmol / -CNE2, 7.2 μmol / L Ce-SUNE, 8.1 μmol / L Ce-CNE1, and 7.6 μmol / L Ce-CNE2 The antiproliferation presented dose- dependent (Nim 5-400 μmol / L, Cel 0.5-80 μmol / L) (Nim IC50 562 μmol / L24, 316 μmol / L4 8, hh 50.1 μmol / L 240) Nim and Cel arrested SUNE and CNE1 cell cycle at phase G2 / M (cell aggregation rate 28.9% -h 45.1% Nim 25-200 μmol-12 h-SUNE, 18.9% -26.2% Nim 25 28.8% -35.6% Nim 25-200 μmol-48 h-SUNE, 30.4% -16.4% Cel 25-100 μmol-12 h-SUNE, 21.2% -19.7% Cel 25-100 μmol- 24 h-SUNE, 31.1% -19.9% Cel 25-100 μmol-24 h-SUNE, 20.5% -34.1% Nim25-200 μmol-12 h-CNE1, 25.2% -26.9% Nim 25-200 μmol-24 h- CNE1, 11.5% -7.1% Nim 25-200 μmol-48 h-CNE1). Apoptosis shape and apoptosis strap displace yed in NPC cells after treatment with Nim and Cel. Nim had a feature of anti-angiogenesis on CAM model. CONCLUSION: Nim and Cel could suppress proliferation of squamous epithelium NPC cells (SUNE, CNE1 and CNE2) through blocking cell cycle and inducing cell apoptosis. Nim could apparently suppress CAM angiogenesis induced by